← Leaderboards
Christopher G. Jackson
University Of Utah
$494,445
Attributed
$494,445
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $179.5K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$494,445 · 3
By mechanism
R21$344,545 · 1
M01$149,900 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Patrick Franklin Kiser$17,126,760
- Markus Amann$6,060,766
- Jeffrey A. Weiss$16,889,073
- Annette Fleckenstein$9,854,317
- Wolfram E Samlowski$2,068,537
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationChondroitinClinical ResearchClinical TrialsCombination ChemotherapyDosageGlucosamineHuman SubjectHuman Therapy EvaluationKneeOsteoarthritisOutcomes ResearchPatient Oriented ResearchAdult Human (21+)Pharmacokinetics
Grant awards (4)
A PHARMACOKINETIC STUDY OF GLUCOSAMINE AND CHONDROITIN$136,476
M01 · FY2006 · RR · contact PI
A Pharmacokinetic Study of glucosamine and chondroitin$166,085
R21 · FY2005 · AT
A PHARMACOKINETIC STUDY OF GLUCOSAMINE AND CHONDROITIN$13,424
M01 · FY2005 · RR
A Pharmacokinetic Study of glucosamine and chondroitin$178,460
R21 · FY2004 · AT